PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Aromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer

2010-12-10
(Press-News.org) SAN ANTONIO — Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis.

These data, presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, indicate that women presenting with breast cancer treatment who have risk factors for cardiovascular disease should be considered for a shorter duration of use of aromatase inhibitors.

"It appears that aromatase inhibitors have a significant increase in cardiotoxic side effects, such as heart attack, angina and heart failure," said Eitan Amir, M.D., a senior fellow in the division of medical oncology and hematology at the Princess Margaret Hospital, Toronto, Canada.

Because some cancers, especially breast cancers, require estrogen to grow and spread, drugs that block estrogen production are often used to treat the disease. Tamoxifen blocks the effect of estrogen in breast tissue, whereas aromatase inhibitors prevent the production of estrogen.

Each class of drugs also have related adverse effects. For example, although tamoxifen blocks estrogen production in breast tissue, it has the opposite effect in uterine tissue. Previous research has shown that extended use of tamoxifen results in a small increase in the risk for endometrial cancer and venous thrombosis.

On the other hand, in December 2008, the Food and Drug Administration added a warning label to anastrozole, an aromatase inhibitor, which indicated potential increased risk for heart disease. For this reason, Amir and colleagues conducted a meta-analysis to determine if this increased risk for heart disease occurred with the use of any aromatase inhibitor.

The researchers examined data from seven large randomized clinical trials that compared tamoxifen with aromatase inhibitors in postmenopausal women with early-stage breast cancer.

Data from the analysis confirmed that any duration of use of an aromatase inhibitor was associated with a 20 percent higher probability of developing cardiovascular disease. However, use of aromatase inhibitors also resulted in a reduced risk for venous thrombosis and endometrial carcinoma.

As a secondary analysis, they determined if switching from treatment with tamoxifen to aromatase inhibitors had any effect on mortality or adverse effects. Results showed that the risk for serious adverse effects were similar when aromatase inhibitors were used as an initial treatment compared with switching to aromatase inhibitors after treatment with tamoxifen.

"However, it appears from the data — and this is strictly hypothesis-generating — that if a woman switches from one drug to another, there is a reduction in the risk from death from causes other than breast cancer," Amir said. "This potentially suggests that there may be side effects that build up the longer a woman is on a certain drug, but switching drugs may reduce the side effects."

### Follow the AACR on Twitter @AACR, and throughout the meeting using the hash tag #SABCS.

Recordings of the teleconferences and video interviews with researchers will posted to the AACR website throughout the meeting: http://www.aacr.org/page23506.aspx.

The mission of the CTRC-AACR San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients. The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine are joint sponsors of the San Antonio Breast Cancer Symposium. This collaboration utilizes the clinical strengths of the CTRC and Baylor, and the AACR's scientific prestige in basic, translational and clinical cancer research to expedite the delivery of the latest scientific advances to the clinic. The 33rd annual symposium is expected to draw nearly 9,000 participants from more than 90 countries.

END



ELSE PRESS RELEASES FROM THIS DATE:

Obese women with ER-positive/HER2-negative breast cancer have poorer survival rates

2010-12-10
SAN ANTONIO — Obesity was associated with worse overall and disease-free survival in women with operable breast cancer treated with adjuvant chemotherapy, but for the first time, researchers observed this finding in only a specific subset of patients – those with estrogen receptor (ER)-positive/HER2-negative disease. About one third of all adults in the United States are obese, posing a major public health problem because of obesity's association with an increased risk of diabetes and heart disease. This study indentified a new hazard associated with obesity. Results ...

Most women do not get recommended mammograms

2010-12-10
SAN ANTONIO — Only half of eligible women in the United States are getting their annual mammograms, even if they have insurance to pay for the procedure, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. Last year the U.S. Preventive Services Task Force, an independent panel of non-federal experts in prevention and evidence-based medicine, recommended that the age of first mammogram be lifted from 40 to 50 years of age, at which biennial mammography begins, and caused a public outcry. To date, no major insurance company or other ...

Estrogen alone is effective for reducing breast cancer risk

2010-12-10
SAN ANTONIO — While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk, according to study results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12. "Our analysis suggests that, contrary to previous thinking, there is substantial value in bringing HRT with estrogen alone to the guidelines. The data show that for selected ...

Results of AZURE to be presented at the CTRC-AACR San Antonio Breast Cancer Symposium

2010-12-10
SAN ANTONIO — The long-awaited results of the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer, the AZURE trial, will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 8-12. "Adjuvant use of bisphosphonates like zoledronic acid is widespread among women with breast cancer, and the results of this trial will help answer many questions as well invite new ones," said Robert Coleman, M.D., professor of medical oncology at the University of Sheffield in England. Coleman will present the results of AZURE during ...

Exemestane may be another first-line, adjuvant therapy for hormone-receptor positive, early-stage breast cancer

2010-12-10
SAN ANTONIO — Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer. In the first head-to-head adjuvant clinical trial comparing two aromatase inhibitors, anastrozole and exemestane, the drugs resulted in similar survival rates and prevention of breast cancer recurrences. Some differences in the side effect profile were seen, including a potential difference in the risk of developing osteoporosis. Paul E. Goss, M.D., Ph.D., professor ...

Genome of barley disease reveals surprises

2010-12-10
Scientists have sequenced the genome of a major fungal disease that affects barley and other cereal crops, a breakthrough that could lead to significant advances in our understanding of how plant diseases evolve. The research, published today in the journal Science, suggests that parasites within the genome of the fungus help the disease to adapt and overcome the plant's defences. The study could help with the development of new agricultural techniques for protecting cereal crops from infection. Barley grains are the basis of many staple foods, and also central to the ...

The end of planet formation, as told by trace elements from the mantles of Earth, the moon and Mars

2010-12-10
New research reveals that the abundance of so-called highly siderophile, or metal-loving, elements like gold and platinum found in the mantles of Earth, the Moon and Mars were delivered by massive impactors during the final phase of planet formation over 4.5 billion years ago. The predicted sizes of the projectiles, which hit within tens of millions of years of the giant impact that produced our Moon, are consistent with current planet formation models as well as physical evidence such as the size distributions of asteroids and ancient Martian impact scars. They predict ...

Gene hunters tackle crop diseases

Gene hunters tackle crop diseases
2010-12-10
Norwich scientists are on the trail of some of the most economically damaging organisms that infect crops worldwide. Their latest targets are the parasitic water fungus that causes powdery mildew and the water molds that cause late blight in potatoes and tomatoes and downy mildew in cruciferous vegetables and other crops. "We have been studying the late blight pathogen for a while," said Professor Sophien Kamoun, head of the Sainsbury Laboratory on the Norwich Research Park. "In separate research we are trialling plant genes that mediate blight resistance, while in this ...

Key protein discovered that allows nerve cells to repair themselves

Key protein discovered that allows nerve cells to repair themselves
2010-12-10
A team of scientists led by Melissa Rolls, an assistant professor of biochemistry and molecular biology at Penn State University, has peered inside neurons to discover an unexpected process that is required for regeneration after severe neuron injury. The process was discovered during Rolls's studies aimed at deciphering the inner workings of dendrites -- the part of the neuron that receives information from other cells and from the outside world. The research will be published in the print edition of the scientific journal Current Biology on 21 December 2010. "We already ...

Thought for food: New CMU research shows imagining food consumption reduces actual consumption

2010-12-10
PITTSBURGH—If you're looking to lose weight, it's okay to think about eating your favorite candy bar. In fact, go ahead and imagine devouring every last bite — all in the name of your diet. A new study by researchers at Carnegie Mellon University, published in Science, shows that when you imagine eating a certain food, it reduces your actual consumption of that food. This landmark discovery changes the decades-old assumption that thinking about something desirable increases cravings for it and its consumption. Drawing on research that shows that perception and mental ...

LAST 30 PRESS RELEASES:

A map for single-atom catalysts

What about tritiated water release from Fukushima? Ocean model simulations provide an objective scientific knowledge on the long-term tritium distribution

Growing crisis of communicable disease in Canada in tandem with US cuts

Women get better at managing their anger as they age

Illegal shark product trade evident in Australia and New Zealand

New search tool brings 21% better accuracy for robotics developers

New model extracts sentence-level proof to verify events, boosting fact-checking accuracy for journalists, legal teams, and policymakers

Efficient carbon integration of CO₂ in propane aromatization over acidic zeolites

FPGA-accelerated AI for demultiplexing multimode fiber towards next-generation communications

Vitamin D3 nanoemulsion significantly improves core symptoms in children with autism: A clinical trial

Microfluidic point-of-care device accurately measures bilirubin in blood serum: A pilot study

Amygdalin shows strong binding and stabilizing effects on HER2 receptor: A computational study for breast cancer therapy

Bond behavior of FRP bars in concrete under reversed cyclic loading: an experimental study

Milky Way-like galaxy M83 consumes high-speed clouds

Study: What we learned from record-breaking 2021 heat wave and what we can expect in the future

Transforming treatment outcomes for people with OCD

Damage from smoke and respiratory viruses mitigated in mice via a common signaling pathway

New software tool could help better understand childhood cancer

Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility

Women 65+ still at heightened risk of cervical cancer caused by HPV

‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk

Effective therapies needed to halt rise in eco-anxiety, says psychology professor

Nature-friendly farming boosts biodiversity and yields but may require new subsidies

Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals

Microplastics discovered in human reproductive fluids, new study reveals

Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa

Novel flu vaccine adjuvant improves protection against influenza viruses, study finds

Manipulation of light at the nanoscale helps advance biosensing

New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance

New study links blood metabolites and immune cells to increased risk of urolithiasis

[Press-News.org] Aromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer